Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
You and your doctor can submit additional information, a letter explaining your situation in more detail, or peer-reviewed studies supporting the treatment
An AquaGold facial is a skin-booster micro-infusion that uses ultra-fine 24K micro-channels to deliver a customized booster blend into the superficial dermis to improve hydration , glow , texture , and the look of pores with minimal downtime
Practical steps to lower heat-related dangers while on GLP-1 drugs Simple habits can reduce risk without stopping therapy
WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk
doi: 10.3389/fphar.2023.1147414 31
